Serum, Bharat Biotech announce 'combined intent' to supply vaccines

The more important task right now is of saving the lives and livelihoods of populations in India and around the world, a joint statement by both companies said

Serum Institute and Bharat Biotech on Tuesday announced their "combined intent" to supply Covid-19 vaccines for India, issuing a joint statement after a controversy over their shots.

"The more important task right now is of saving the lives and livelihoods of populations in India and around the world. Vaccines are a global public health good and they have the power to save lives," said the statement signed by Serum Institute CEO Adar Poonawalla and Krishna Ella, chairperson of Bharat Biotech.
 

"Both our companies are fully engaged in this activity and consider it our duty to the nation and the world